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Lymphocytes are able to sense extracellular 
directional chemoattractant gradients and 
to respond with asymmetric changes in cell 
morphology (polarization) and mobility (che-
motaxis). Cell polarization and chemotaxis de-
pend on the signaling of seven-transmembrane 
receptors coupled to heterotrimeric Gi proteins 
(G protein–coupled receptors). To achieve di-
rected movement, cells organize and maintain 
spatial and functional asymmetry with a defi ned 
anterior (leading edge) and posterior (uropod) 
(1, 2). In lymphoid cells, the leading edge con-
tains the cell machinery for actin polymeriza-
tion and gradient sensing, whereas the uropod 
contains certain adhesion molecules, the mi-
crotubule organizing center (MTOC), and the 
majority of cellular organelles and cytoplasmic 
volume (3).
Mitochondria, highly mobile and dynamic 
organelles (4), can accumulate in subcellular re-
gions requiring high metabolic activity, such as 
active growth cones of developing neurons (5) 
or dendritic protusions in spines and synapses (6). 
Intracellular distribution of mitochondria is 
controlled by their movement along micro-
tubules, mediated by kinesin and dynein motors. 
This is coordinated with changes in the mor-
phology of the organelles. Mitochondrial shape 
results from a regulated balance between fusion 
and fi ssion events, tightly controlled by a grow-
ing family of so-called “mitochondria-shaping” 
proteins. These include both profusion mem-
bers, such as the large dynamin-like GTPases 
Opa1 and mitofusin (Mfn) 1 and 2, and profi s-
sion members, such as the cytosolic GTPase 
dynamin-related protein 1 (Drp1) and its outer 
mitochondrial membrane adaptor hFis1 (7). To 
move, the extensive mitochondrial network 
must be divided into smaller organelles that can 
be readily cargoed by plus- and minus-end di-
rected motors (8). To this end, the machinery 
that transports mitochondria is likely coordi-
nated with mitochondria-shaping proteins, as 
substantiated by the fi nding that disruption of 
the dynein complex results in mitochondrial 
elongation dependent on Drp1 blockage (9).
Mitochondria cluster at the site of high 
ATP demands in diff erent cell types, and previ-
ous studies suggested a possible direct functional 
interaction between these ATP-producing 
organelles and ATP-consuming cellular struc-
tures (6, 10–13). It has been recently demon-
strated that in Drosophila neuromuscular junctions, 
mitochondria positioning at the synapse is 
 required to fuel the myosin ATPase that mobi-
lize reserve pool vesicles (13). Whether, how, 
or why mitochondria redistribute during lym-
phocyte migration is totally unknown.
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Lymphocyte traffi c is required to maintain homeostasis and perform appropriate immuno-
logical reactions. To migrate into infl amed tissues, lymphocytes must acquire spatial and 
functional asymmetries. Mitochondria are highly dynamic organelles that distribute in the 
cytoplasm to meet specifi c cellular needs, but whether this is essential to lymphocyte 
functions is unknown. We show that mitochondria specifi cally concentrate at the uropod 
during lymphocyte migration by a process involving rearrangements of their shape. Mito-
chondrial fi ssion facilitates relocation of the organelles and promotes lymphocyte chemo-
taxis, whereas mitochondrial fusion inhibits both processes. Our data substantiate a new 
role for mitochondrial dynamics and suggest that mitochondria redistribution is required to 
regulate the motor of migrating cells.
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In this study, we demonstrate that mitochondria are trans-
ported to the uropod along microtubules during lymphocyte 
migration in a process requiring Gi protein signaling and mi-
tochondrial fi ssion. By interfering with the expression of 
mitochondria-shaping proteins that regulate the dynamics of 
the organelles, we show that fusion-fi ssion of mitochondria 
constrains lymphocyte polarization and migration. Our data 
suggest that accumulation of mitochondria at the uropod of 
a migrating cell is required to regulate the cell motor of 
migrating lymphocytes.
RESULTS
Mitochondria concentrate at the uropod 
of migrating lymphocytes
To analyze mitochondria dynamics during leukocyte migra-
tion, we expressed a mitochondrially targeted red fl uorescent 
protein (mtRFP) or yellow fl uorescent protein (mtYFP) in 
Jurkat T cells, human peripheral blood T cells (PB T cells), 
and diff erentiated HL-60 (dHL-60) myelocytic cells, a model 
neutrophil-like cell line. In all of the following experiments, 
mitochondria were visualized using either mtRFP or mtYFP, 
obtaining identical results. Mitochondrial positioning was 
analyzed in response to chemotactic factors such as CXC 
chemokine ligand (CXCL) 12 or CC chemokine ligand 
(CCL) 21 for Jurkat and PB T cells or the tripeptide attrac-
tant N-formyl-Met-Leu-Phe (fMLP) for dHL-60 cells. In 
polarized T cells, mitochondria concentrated in a region of 
the cell corresponding to the uropod (Fig. 1 and Videos S1 
and S2, available at http://www.jem.org/cgi/content/full/
jem.20061877/DC1), as indicated by colocalization of the or-
ganelles with the uropodal marker CD44 (Fig. 1, G and H) (14).
Similar results were obtained using dHL-60 cells express-
ing mtRFP to visualize mitochondria and the pleckstrin ho-
mology domain of AKT fused to GFP (AKTPH-GFP) to 
visualize the leading edge (15). We found that uropod redis-
tribution of mtRFP paralleled the AKTPH-GFP accumula-
tion at the leading cell edge (Fig. 2 and Video S3, available 
at http://www.jem.org/cgi/content/full/jem.20061877/DC1), 
demonstrating that mitochondria specifi cally redistribute to 
and accumulate at the uropod during directed leukocyte 
migration. The specifi c accumulation of mitochondria at the 
uropods of migrating leukocytes was further confi rmed in 
experiments in which the distribution of mitochondria was 
compared with the distribution of the endoplasmic reticulum 
in Jurkat T cells (Fig. 3, A and B) or the cytoplasm in dHL-60 
cells (Fig. 3 C). These fi gures clearly indicate that the loca-
tion of mitochondria during leukocyte chemotaxis is specifi c 
and not a consequence of space constraints. Similar results 
were obtained using human PB B cells stimulated with 
CXCL12 and the human breast cancer cell line MCF7 stimu-
lated with insulin-like growth factor–I, indicating that redis-
tribution of mitochondria to the rear edge is a general event 
occurring in migrating cells (Fig. S1).
Mitochondria redistribution requires Gi protein signaling 
and microtubule integrity
Classically, one of the initial events in chemoattractant recep-
tor signaling is the physical association of heterotrimeric Gi 
proteins to the receptor, leading to the inhibition of ade-
nylate cyclase and intracellular calcium mobilization (16). 
Nonetheless, chemokine receptors may be coupled to other 
G proteins upon ligand stimulation in specifi c circumstances 
(17, 18). We found that Pertussis toxin (PTx) treatment (19) 
inhibits CXCL12-induced mitochondria redistribution in 
T cells (Fig. 4), thus confi rming that mitochondria polariza-
tion is coupled to Gi-induced signaling.
Figure 1. Mitochondria accumulate at the uropod of polarized 
lymphocytes. (A–D) Distribution of mitochondria (mtRFP) in Jurkat T cells 
untreated (A and B) or polarized with 100 nM CXCL12 (C and D). 310 un-
treated and 395 polarized cells were analyzed. (B and D) Volume-rendered 
three-dimensional reconstructions of mitochondrial networks (see also 
Videos S1 and S2). (E–H) Distribution of mitochondria (mtRFP) in PB T 
cells resting (E and F) and polarized with 100 nM CCL21 (G and H). Staining 
of the uropod marker CD44 (blue) is shown. 59 resting and 45 polarized 
PB T cells were analyzed. Bars, 5 μm.
Figure 2. Mitochondria accumulate at the uropod of a migrating 
leukocyte. fMLP-induced migration of dHL-60 cells expressing mtRFP 
and AKTPH-GFP monitored by time-lapse confocal microscopy. Images 
were taken at 5-s intervals. Representative images taken from the digital 
movie (Video S3) at the indicated times are shown. 14 cells expressing 
mtRFP and AKTPH-GFP were analyzed by real-time microscopy, and all of 
them showed a similar segregation of AKTPH-GFP to the leading edge and 
of mitochondria to the uropod. Bar, 5 μm.
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Phosphoinositide 3–kinase (PI3K)–dependent signaling 
pathways have been suggested to play pivotal roles in deter-
mining lymphocyte chemotaxis. However, there is a grow-
ing body of evidence indicating that PI3K activation can be 
a dispensable signal for directed cell migration in certain set-
tings (20). Thus, in our experiments, PI3K inhibition by 
wortmannin did not result in impaired mitochondria polar-
ization in response to CXCL12 (Fig. 4).
Chemotaxis requires a concerted dialog between the ac-
tin and microtubule cytoskeletons (21). Polarity and migra-
tion depend on the dynamic polymerization of fi lamentous 
actin at the leading edge (22), whereas the MTOC and mi-
crotubules radiating from it direct vesicular traffi  c and main-
tain cell polarization (23). Moreover, microtubules are 
docking sites for motors that actively transport cytoplasmic 
organelles such as mitochondria (24). Mitochondria redistri-
bution after chemokine receptor signaling was inhibited 
in cells treated with the microtubule-depolymerizing drug 
nocodazole but, conversely, remained unaff ected by latrun-
culin, which depolymerizes fi lamentous actin (Fig. 4). Thus, 
microtubule but not actin cytoskeleton is involved in the re-
cruitment of mitochondria to the T cell uropod.
Mitochondria accumulation at the cell uropod requires 
fi ssion of the organelles
A key question is whether mitochondria accumulation at the 
uropod is a bystander eff ect owing to MTOC polarization or, 
in contrast, if mitochondria asymmetry is strategic for lym-
phocyte migration. To address this point, it would be neces-
sary to inhibit mitochondria polarization without aff ecting 
their functional activities and without interfering with other 
cell organelles. Dynamic control of mitochondrial structure 
is performed by a set of mitochondria-shaping proteins, in-
cluding both profusion and profi ssion members (25). Mito-
chondrial fi ssion is regulated by Drp1, which migrates to 
mitochondrial membranes at sites of fragmentation, where it 
binds to its adaptor hFis1 (26–27). Mitochondrial fusion re-
quires the action of Mfn1 and Mfn2 and of the inner mem-
brane dynamin-related protein Opa1 (28, 29). Manipulation 
of fusion-fi ssion equilibrium often results in redistribution of 
the organelles in the cytoplasm (30). Thus, we expressed 
DRP1 and OPA1 to manipulate mitochondrial morphology 
(and distribution) in T lymphocytes. OPA1, as well as DRP1, 
did not alter mitochondrial membrane potential, as measured 
by accumulation of the potentiometric fl uorescent dye tetra-
methyl rhodamine methyl ester, total cellular ATP concen-
tration (Figs. S2 and S3, available at http://www.jem.org/cgi/
content/full/jem.20061877/DC1), or actin polymerization 
and localization (not depicted). In Jurkat T cells, compared 
with control cells (Fig. 5, A and B; and Video S4), DRP1 in-
duced mitochondrial division (80% of the cells), aggregation, 
and perinuclear clustering (Fig. 5, D and E; and Video S5). 
Figure 3. Specifi c accumulation of mitochondria in polarized 
leukocytes. (A and B) Distribution of mitochondria (mtRFP) and the endo-
plasmic reticulum (erGFP) in Jurkat T cells untreated (A) or polarized with 
100 nM CXCL12 (B). (C) Distribution of mitochondria (mtRFP) and cyto-
plasm (GFP) in dHL-60 cells polarized with 100 nM fMLP. The fl uorescence 
patterns reported in these panels were representative of at least 90% of 
the cells. Bars, 5 μm.
Figure 4. Mitochondria recruitment to the T cell uropod depends 
on Gi protein signaling and microtubule dynamics. Jurkat T cells ex-
pressing mtRFP were incubated with 1 μg/ml PTx, 100 nM wortmannin, 
30 μM nocodazole, or 10 μM latrunculin, and polarization was induced 
with 100nM CXCL12. (A) Images of mtRFP fl uorescence from randomly 
selected cells (78 cells in the PTx experiment, 84 cells in the wortmannin 
experiment, 85 cells in the nocodazole experiment, and 82 cells in the 
latrunculin experiment) were acquired, analyzed, and classifi ed as de-
scribed in Materials and methods. The analysis includes all the cells, and 
in all these experiments <12% of cells contained polarized mitochondria 
in the absence of the chemokine. The number of cells showing polarized 
shape was similar to the number of those showing polarized mitochon-
dria in the case of PTx, wortmannin, and latrunculin experiments. When 
nocodazole was used, 35% of the cells were polarized. Data represent 
mean ± SE of at least three independent experiments. *, P ≤ 0.05 com-
pared with control cells. (B) Representative images taken from the digital 
movie at the indicated times are shown. Images were taken at 5-s intervals. 
At least 10 cells were analyzed by real-time microscopy for each condition. 
Bars, 5 μm.
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In contrast, mitochondria expressing OPA1 formed a tubular 
network (65% of the cells) spanning the entire cytoplasm 
(Fig. 5, G and H; and Video S6). In response to CXCL12, 
DRP1-transfected cells polarized to the same extent as con-
trol cells (61% of the cells; Fig. 5 F). In contrast, OPA1 
blocked mitochondrial and cell polarization in response to 
the chemokine (13% of the cells showed polarized mito-
chondria; Fig. 5 I). Similar results were obtained with PB T 
lymphocytes (not depicted). These data indicate that mito-
chondrial redistribution to the uropod critically depends on 
unperturbed fi ssion of the organelle. This, in turn, appears to 
be crucial to coordinate chemokine-induced polarization of 
the cell and therefore suggests a role for mitochondria in 
 regulating migration.
Mitochondrial shape constrains lymphocyte migration
We next addressed whether fusion-fi ssion of mitochondria or-
chestrates lymphocyte chemotaxis by expressing mitochon-
dria-shaping proteins that regulate dynamics of the organelles. 
We found that OPA1, MFN1, and a dominant-negative mu-
tant of DRP1 (K38A-DRP1) (31)—which promote fusion 
or inhibit fi ssion of mitochondria, respectively—prevented 
migration of PB T lymphocytes toward CXCL12 gradients 
(Fig. 6). Conversely, the profi ssion molecule DRP1 or a 
 dominant-negative mutant of OPA1 (K301A-OPA1) that in-
hibits fusion (29) stimulated PB T cell chemotaxis (Fig. 6). 
Similar results were obtained with Jurkat cells in response to 
CXCL12 and with dHL-60 cells in response to fMLP (not 
depicted). The point mutants of OPA1 and DRP1 further 
substantiate a specifi c eff ect of impinging on the fusion-fi ssion 
equilibrium, rather than an unspecifi c eff ect of the wild-type 
proteins of cellular functions. The eff ect of OPA1 on T cell 
polarization and chemotaxis was further analyzed in time-lapse 
experiments showing that OPA1-overexpressing cells are unable 
to migrate toward a CXCL12 gradient (Video S7, available at 
http://www.jem.org/cgi/content/full/jem.20061877/DC1).
Mitochondrial ATP is required during T cell migration
All of these data demonstrate that fi ssion of mitochondria, 
epistatic to organelle recruitment to the uropod, constrain 
lymphocyte polarization and migration. In neurons, mito-
chondria are present throughout the axon, but they accumu-
late where the need for ATP production is especially high 
(5, 6, 13). ATP can be synthesized both via oxidative phos-
phorylation in mitochondria and via glycolysis in the cytosol. 
To address whether production of mitochondrial ATP is spe-
cifi cally required during cell migration, we took advantage of 
the well-known glycolytic properties of Jurkat T cells (32, 33). 
Oligomycin, a specifi c inhibitor of the mitochondrial F1F0-
ATPase, did not decrease total cellular ATP in Jurkat T cells, 
confi rming that these cells mainly rely on glycolytic ATP 
production for their energetic demands (not depicted). Thus, 
oligomycin did not prevent chemokine-induced mitochon-
dria redistribution, as well as cell polarization (Fig. 7 A), dem-
onstrating that these processes do not require ATP production 
by mitochondria. However, under the same conditions, T cell 
migration was impaired, suggesting that glycolytic T cells 
Figure 5. Mitochondria fi ssion is required for recruitment of the 
organelles to the cell uropod. Jurkat T cells were cotransfected with 
mtRFP and empty vector (A–C), mtRFP and DRP1 (D–F), or mtRFP and 
OPA1 (G–I), and mitochondrial shape in resting (A, B, D, E, G, and H) or 
polarized (C, F, and I) cells was analyzed by confocal microscopy. Bar 
graphs next to images in the fi gure indicate the frequency of the phe-
nomenon represented. *, P ≤ 0.0001 compared with polarized control 
cells. When transfected with DRP1, 80% of 167 analyzed cells showed 
fragmented mitochondria as in E; after chemokine treatment, 61% of 
150 cells showed the polarized phenotype shown in F. In contrast, 
when OPA1 was expressed, 65% of 169 analyzed cells showed fused 
mitochondria as in H, whereas 87% of 180 cells showed the impaired 
polarization in response to chemokine shown in I. In control cells (C), 
CXCL12 induced mitochondria polarization in 60% of 395 analyzed cells. 
(A, D, and G) Volume-rendered three-dimensional reconstructions of 
mitochondrial network (see also Videos S4, S5, and S6). Data represent 
mean ± SE. Bar, 5 μm.
Figure 6. Lymphocyte polarization and migration is regulated by 
mitochondrial shape. Mitochondrial fusion-fi ssion constrains lym-
phocyte polarization and migration. PB T lymphocytes were cotransfected 
with mtRFP and empty vector (control) or with mtRFP and wild-type 
MFN1, wild-type OPA1, dominant-negative OPA1 (K301A-OPA1), wild-
type DRP1, or dominant-negative DRP1 (K38A-DRP1). T cells were ex-
posed to a CXCL12 gradient, and transmigrated cells were counted. In all 
the experiments, the background migration was almost absent (<0.1% of 
the loaded cells did migrate in the absence of chemokines) and was not 
modifi ed by mitochondria manipulation. Data are representative of at 
least three different experiments and are expressed as mean ± SE. 
*, P ≤ 0.05 compared with control cells.
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require mitochondrial ATP production at the uropod to 
 migrate (Fig. 7 B). Notably, oligomycin also inhibited migra-
tion of DRP1-overexpressing Jurkat T cells (Fig. 7 B), indi-
cating that the promoting eff ect of DRP1 expression on 
lymphocyte migration is linked to its capacity to favor 
mitochondria concentration and, therefore, ATP production 
at the uropod.
If the inhibitory eff ect of OPA1 on migration is cause by 
reduced density of mitochondria (and ATP concentration) at 
the uropod, we reasoned that enhancement of mitochondrial 
respiration by creatine should restore lymphocyte chemotaxis 
in OPA1-overexpressing cells. Pharmacological enhance-
ment of mitochondrial function has been shown a valuable 
approach to demonstrate the relevance of mitochondrial lo-
calization for synapse density (6). Treatment of Jurkat T cells 
with 20 mM creatine corrected migration defects induced by 
OPA1 overexpression (Fig. 7 B), demonstrating that, when 
mitochondria are evenly distributed in the cytoplasm, the 
increased ATP availability in specifi c cell areas is limiting 
for chemotaxis.
Class II myosins are heterohexamers that self-assemble 
into bipolar multimeric fi laments and move along actin fi la-
ments in an ATP-dependent manner. This myosin fi laments 
contract actin fi laments and provide tension required for cell 
movement. Myosin II activity is mainly controlled through 
the phosphorylation of the myosin light chain (MLC), which 
induces a conformational change allowing actiomyosin inter-
actions and activating its ATPase activity (34). Inhibition of 
the myosin II ATPase activity specifi cally prevents polarity 
and motility in T cells (35). To address whether mitochon-
drial ATP is required to sustain phosphorylation of the MLC 
at the rear of migrating cells, T cells pretreated with oligomy-
cin were exposed to CCL21 and stained for the MLC phos-
phorylated form (Fig. 8). In control cells, CCL21 induced 
MLC phosphorylation at both the rear and the leading edges, 
whereas the fl uorescence intensity was more intense at the 
cell uropod (Fig. 8, A–C). When T cells were pretreated 
with oligomycin, MLC phosphorylation was specifi cally in-
hibited at the cell uropod (Fig. 8 D). Collectively, these data 
indicate that mitochondrial ATP is essential to sustain MLC 
phosphorylation in migrating cells.
D I S C U S S I O N 
Mitochondrial shape changes are being increasingly recog-
nized as players in the cellular processes of Ca2+ signaling and 
apoptosis (25, 36). Whether mitochondrial shape changes can 
regulate complex cellular responses remains largely unclear, 
albeit some indications recently emerged in neurons. Mito-
chondrial redistribution to dendritic protrusions supports the 
ability of neurons to form new excitatory synapses in response 
to stimulation. Inhibition of this redistribution by mitochon-
dria-shaping proteins like OPA1 and dominant-negative 
DRP1 led to a decreased density of spines and synapses (6).
In this study, we unravel a previously unexpected role for 
these morphological adaptations in the immune system, 
Figure 7. Mitochondrial ATP is required during T cell migration. 
(A) Oligomycin does not inhibit CXCL12-induced mitochondria redis-
tribution to the Jurkat T cell uropod (88 cells analyzed). Bar, 5 μm. 
(B) Mitochondria respiration is limiting in chemotaxis. Control, DRP1-, or 
OPA1-overexpressing T cells were exposed to a CXCL12 gradient. After 2 h, 
transmigrated cells were counted. Where indicated, either Jurkat T cells 
were pretreated with 20 mM creatine or 0.4 μM oligomycin was added to 
the medium. Data are representative of three different experiments and 
are expressed as mean ± SE. *, P ≤ 0.05 compared with control cells; 
**, P ≤ 0.05 compared with untreated DRP1-overexpressing cells; 
***, P ≤ 0.05 compared with untreated OPA1-overexpressing cells.
Figure 8. Mitochondrial ATP is required to sustain MLC phosphor-
ylation. (A and B) Stimulation of T cells with chemokines induces MLC 
phosphorylation. PB T cells unstimulated (A) or polarized with CCL21 (B) 
were stained with anti-pMLC antibody and analyzed by confocal micros-
copy. Bars, 20 μm. (C and D) Inhibition of mitochondrial ATP production 
results in specifi c loss of MLC phosphorylation at the uropod. T cells ex-
pressing the mitochondrial marker mtRFP, pretreated (D) or not (C) with 
oligomycin, were stimulated with 100 nM CCL21, stained with anti-pMLC 
antibody, and analyzed by confocal microscopy. At least 50 cells were 
observed and analyzed for each condition. Bars, 5 μm.
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where they master movement of lymphocytes to chemoat-
tractants. We demonstrate that lymphocyte chemotaxis is 
regulated by the ability of mitochondria to relocate at the 
uropod and, hence, by unopposed fi ssion of the organelles. 
Indeed, the lengthened mitochondria resulting from overex-
pression of profusion proteins (OPA1, MFN1, or mutant 
DRP1) or knockdown of a profi ssion molecule (DRP1) 
might be too taxing for microtubule-mediated transportation 
to the cell uropod. In contrast, overexpression of mitochon-
drial profi ssion molecules (DRP1 or mutant OPA1) or 
knockdown of a profusion protein (OPA1) facilitates trans-
port of the organelles and promotes lymphocyte polarization 
and migration. These results indicate that redistribution of 
this organelle requires an unperturbed balance between fu-
sion and fi ssion. In more detail, conditions that shift this bal-
ance toward fusion interfere with relocation of mitochondria 
at the uropod. This inhibition of mitochondrial transport 
could refl ect an inability to cargo organelles that are too large 
or a specifi c interference of the fusion-fi ssion machinery with 
mitochondria-specifi c motors. Independent from the mecha-
nism, when mitochondria do not relocate properly, polariza-
tion and migration is impeded.
Functional microcompartmentalization of intracellular 
metabolites (including adenine nucleotide) and substrates has 
long been recognized (10, 11). Our data indicate that accu-
mulation of mitochondria at the uropod of a migrating cell is 
required to ensure high ATP in this strategic position, where 
class II myosin proteins, major cellular motors, are selectively 
localized (37).
It may be argued that, rather than for ATP, mitochondria 
play a key role in chemotaxis because of their capacity to se-
quester calcium ions. We performed several experiments to 
analyze the possible role of calcium signals during lympho-
cyte migration. First, no inhibition of lymphocyte migration 
toward a CXCL12 gradient was observed in a Ca2+-free me-
dium (RPMI plus 2 mM EGTA; not depicted). Second, no 
specifi c inhibition was observed when intracellular calcium was 
buff ered using 5, 10, or 20 μM 1,2-Bis(2-aminophenoxy)ethane-
N,N,N’,N’-tetraacetic acid (not depicted). Third, DT40 
(B lymphocyte cell line) triple inositol 1,4,5-trisphosphate 
receptor–knockout cells migrated toward CXCL12 gradients 
as effi  ciently as wild-type cells (not depicted). Collectively, 
these data confi rm that calcium signaling does not play a criti-
cal role during lymphocyte migration (38, 39).
In Drosophila neuromuscular junctions, mitochondria po-
sitioning at the synapse requires DRP1 function and is neces-
sary to fuel the myosin ATPase that mobilizes reserve pool 
vesicles (13). Uropodal ATP generated by redistributed mi-
tochondria could therefore be pivotal in fuelling the actomy-
osin cell motor, a key step in high-speed moving cells, such 
as T cells and leukocytes, in which migration likely occurs 
through an extrusive process based in the uropod.
MATERIALS AND METHODS
Cells. PB T cells were sorted by negative selection using a RosetteSep kit 
(StemCell Technologies Inc.). Jurkat E6.1, PB T, and HL-60 cells were 
 cultured in RPMI 1640 medium (Euroclone) supplemented with 10% FCS, 
2 mM l-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin. 
HL-60 cell diff erentiation in dimethyl sulfoxide was performed as previously 
described (40). MCF7 breast cancer cells from the American Type Culture 
Collection were maintained in MEM with 10% FCS, l-glutamine, sodium 
pyruvate, and nonessential amino acids. Blood from healthy donors was 
 provided by the University Hospital (Centro Immunotrasfusionale, Padua, 
Italy), which approved the use of donor blood for laboratory experiments 
and obtained informed consent from all subjects.
Constructs and transfections. The empty pcDNA3.1 and pMSCV were 
obtained from BD-Clontech. mtRFP and mtYFP plasmids, as well as the 
GFP targeted to the endoplasmic reticulum were a gift from T. Pozzan 
(Venetian Institute of Molecular Medicine, Padua, Italy). The pGFP–glycosyl 
phosphatidylinositol (GPI) plasmid was a gift from P. Keller (Max-Planck-
Institute, Dresden, Germany). pMSCV-OPA1, pMSCV-K301A-OPA1, 
pCB6-MYC-MFN1, pcDNA3.1-HA-DRP1, and pcDNA3.1-HA-K38A-
DRP1 plasmids were previously described (29). PHAKT-GFP was obtained 
as previously described (41).
Jurkat and dHL-60 cell transfection was performed as previously de-
scribed (40, 41). In brief, the cDNA constructs were transfected by electro-
porating 50 μg DNA. In cotransfections, 20 μg of marker-carrier (GFP-GPI 
in transwell experiments or mtRFP in polarization experiments) plus 30 μg 
of empty pcDNA3.1 or pMSCV-OPA1, pMSCV-K301A-OPA1, pCB6-
MYC-MFN1, pcDNA3.1-HA-DRP1, or pcDNA3.1-HA-K38A-DRP1 
were used. The specifi c combination of plasmids transfected in each experi-
ment is indicated in the fi gure legends. After 24 h, transfected cells were used 
for experiments (in experiments with transiently transfected cells) or were 
cultured in 2 mg/ml geneticin-containing medium (G418; Invitrogen) to 
obtain stably transfected cells.
PB T cells were transiently transfected using an eletroporation system 
(Amaxa Biosystems) according to the manufacturer’s guidelines and were 
used for experiments 24 h later. MCF-7 cells were transfected with Lipo-
fectamine Plus (Invitrogen) according to the manufacturer’s instructions.
Polarization assays. Jurkat or PB T and B cells, expressing mtRFP alone 
or in combination with OPA1 or DRP1, were plated on microscope slides 
coated with 10 μg/ml fi bronectin (Sigma-Aldrich) 12 h before assay. After 
4 h of serum starvation, cells were stimulated with 100 nM CXCL12 or 
CCL21 (PeproTech) for 15 min at 37°C. Cells were fi xed in 2% paraformal-
dehyde for 15 min at room temperature, washed, and mounted in 2.5% 
1,4-diazobicyclo[2.2.2]octane (Fluka) in a solution of 90% glycerol and 10% 
PBS. For pMLC or CD44 stainings, after fi xation, cells were permeabilized 
with 0.1% Triton X-100 for 4 min at room temperature and incubated with 
primary (anti-pMLC2, 1:100 [Cell Signaling Technology]; anti-CD44, 
1:100 [BD Biosciences]) and secondary reagents. The Cell Signaling anti-
body is a mouse monoclonal antibody specifi c for endogenous levels of 
MLC2 only when phosphorylated at Ser 19 (42–44). It shows cross-reactivity 
with the human mouse and rat pMLC2. The specifi city of the pMLC2 stain-
ing was verifi ed by treating the cells with the ROCK inhibitor Y27632, 
which inhibits MLC phosphorylation (not depicted).
Serum-starved mtRFP-transfected MCF7 cells seeded on vitronectin-
coated eightwell chamber glass slides were stimulated for 30 min at 37°C 
with 20 ng/ml insulin-like growth factor–I, a chemoattractant for this 
cell line (45).
In some assays, T cells were pretreated with 0.12 or 0.4 μM oligomycin 
(Sigma-Aldrich) for 5 min at 37°C; 1 μg/ml PTx (Calbiochem) for 4 h at 
37°C; 30 μM nocodazole (Sigma-Aldrich) for 1 h at 37°C; 10 μM latrunculin 
(Calbiochem) for 30 min at 37°C; or 100 nM wortmannin (Sigma-Aldrich) 
for 30 min at 37°C. All of these substances were also present during the 
polarization process.
Confocal microscopy. For confocal images, microscope slides were placed 
on the stage of an inverted microscope (TE300; Nikon Eclipse) equipped 
with a spinning-disk confocal system (UltraVIEW LCI; PerkinElmer), 
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a piezoelectric z axis motorized stage (PIFOC; Physik Instrumente), and 
a 12-bit charge-coupled device camera (ORCA ER; Hamamatsu Photonics). 
Cells expressing mtRFP were excited using the 568-nm line of the Kr/Ar 
laser (PerkinElmer) by using a 100× 1.3 NA Plan Fluor objective (Nikon). 
Emitted light was collected with a fi lter (HQ607/45m; Chroma Technology 
Corp.). Stacks of images separated by 0.3 μm along the z axis were acquired. 
In some experiments, the Olympus confocal system FV10 was used.
Digital images were processed using the National Institutes of Health 
ImageJ 1.32J and Adobe Photoshop 7.0 programs. Three-dimensional re-
construction and volume rendering of the mitochondria stacks were per-
formed with ImageJ software.
Time-lapse confocal videomicroscopy and chemotaxis assays. Real-
time cell mitochondrial dynamics in dHL-60 or Jurkat cells were studied by 
time-lapse confocal microscopy, as previously described (40). In brief, starved 
cells were plated on fi bronectin-coated chamber coverslips (Nunc) and che-
motaxis assayed at 37°C by supplying 100 nM fMLP (Sigma-Aldrich) or 
100 nM CXCL12 through a 1–2 μm micropipette controlled by a micro-
manipulation system (Narishige). Fluorescence and phase-contrast images 
were recorded every 5 s until the cell reach the pipette tip using a confocal 
microscope (TCS 4PI; Leica). In other experiments (Fig. 4), real-time mito-
chondrial dynamics in Jurkat cells were analyzed using the TILL Photonics 
video imaging systems (Olympus). Starved cells were plated on fi bronectin-
coated chamber coverslips (Nunc) and polarization assayed at 37°C by sup-
plying 0.1 μM CXCL12. Images were processed with ImageJ software.
Migration assays. Transiently transfected Jurkat, PB T, or dHL-60 cells 
were resuspended in serum-free RPMI 1640 with 0.1% BSA and seeded in 
the upper chamber of a transwell plate (Corning Costar). The lower cham-
bers were fi lled with RPMI-BSA, with or without the chemoattractant (25 nM 
CXCL12 for Jurkat cells, 2.5 nM CXCL12 for PB T, and 100 nM fMLP for 
dHL-60). To discriminate between chemotaxis and chemokinesis, the same 
concentration of chemoattractant was added in both the upper and the lower 
chamber of the transwell. Transwell plates were kept at 37°C in 5% CO2 for 
2 h. The lower chamber medium, containing the transmigrated cells, was 
recovered, and the number of cells was counted with a FACSCalibur 
(Becton Dickinson). In some assays, 0.4 μM oligomycin was added to the 
medium (in both compartments). Creatine treatment (6) was performed by 
culturing T cells in 20 mM creatine for 12 h.
Mitochondrial membrane potential measurements. The mitochon-
drial membrane potential of Jurkat and PB T cells sorted after cotrasfection 
with mtRFP plasmid and empty pcDNA3.1, or pMSCV-OPA1 or 
pcDNA3.1-HA-DRP1, was performed as previously described (46). In 
brief, after cell sorting, 106 cells were resuspended in Krebs Ringer buff er 
(125 mM NaCl, 5 mM KCl, 1 mM Na2PO4, 1 mM MgSO4, 20 mM Hepes, 
pH 7.4) in the presence of 10 nM tetramethylrhodamine methyl ester 
(TMRM; Invitrogen) and 2 μg/ml CsH (a gift from Novartis, Basel, 
Switzerland). After a 30-min incubation at 37°C, TMRM fl uorescence in-
tensity was estimated by fl ow cytometry on a FACSCalibur before and after 
addition of 2 μM carbonyl cyanide 4-(trifl uoro-methoxy)phenylhydrazone 
(Sigma-Aldrich) to the samples.
Cellular ATP measurements on lysate cells/cellular ATP assays. 
Measurement of intracellular ATP content was performed using a luminom-
eter (TD-20/20; Turner Designs) and a system bioluminescence detection 
kit (ENLITEN; Promega), according to the manufacturer’s instructions, 
using cellular lysates from 2 × 105 cells. ATP assay was performed in Jurkat 
cells preincubated with 0.12 or 0.4 μM oligomycin for 2 h or in Jurkat cells 
expressing OPA1 or DRP1.
Statistical analysis. Image analysis was performed blind to the treatment 
conditions. For each experimental condition, 20 or 30 confocal cell images 
were randomly taken from diff erent wells of the microscope slide. After 
processing, images were observed and classifi ed by three diff erent operators. 
All data are expressed as means ± SE, as indicated in the fi gure legends. All 
analyses were performed in triplicate or greater, and means obtained were 
used for independent Student’s t tests (Microsoft Offi  ce and Origin 7.0 
Professional). All of the experiments were repeated at least three times. p-values 
to set statistical signifi cance are specifi cally indicated in the fi gure legends.
For cytometric analyses, the Kolmogorov-Smirnov test for analysis of 
histograms was used according to the CellQuest software guide (BD Bio-
sciences), with D/s values >10 considered signifi cant.
Online supplemental material. To show mitochondria relocation at the 
rear edge of polarized cells, we performed three-dimensional reconstructions 
of resting (Video S1) or polarized (Video S2) Jurkat T cells expressing the 
mitochondrial marker mtRFP. Fig. S1 shows mitochondria accumulation at 
the rear edge of polarized MCF7 cells (A and B) and human B lymphocytes 
(C and D), indicating that relocation of the organelles upon cell polarization 
is not restricted to lymphocytes. Video S3 shows real-time mitochondrial 
dynamics in dHL-60 cells migrating toward a chemoattractant gradient.
To alter mitochondria morphology in T cells, we expressed profi ssion 
or profusion proteins. Videos S3–S5 represent three-dimensional recon-
structions of mitochondria in cells transfected with mtRFP and empty vector 
(Video S3), mtRFP and DRP1 (Video S4), or mtRFP and OPA1 (Video 
S5). Figs. S2 and S3 indicate that mitochondria-shaping proteins do not alter 
mitochondrial membrane potential (Fig. S2) and intracellular ATP concen-
tration (Fig. S3). Finally, Video S7 shows that T cells expressing OPA1 do 
not polarize their mitochondria and do not migrate toward a chemoattrac-
tant gradient. Online supplemental material is available at http://www.jem.
org/cgi/content/full/jem.20061877/DC1.
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